Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00797
|
|||||
Drug Name |
NVP-LAQ824
|
|||||
Synonyms |
Dacinostat; (2E)-N-hydroxy-3-(4-{[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl}phenyl)prop-2-enamide; (2E)-N-hydroxy-3-[4-({(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide; (E)-N-Hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]meth yl]phenyl]prop-2-enamide; (E)-N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide; 404951-53-7; CHEMBL356066; Dacinostat; Dacinostat [INN]; LAQ-824; LAQ824; LAQ824 (Dacinostat); LBH539; NVP-LAQ 824; NVP-LAQ824, Dacinostat, LAQ824; UNII-V10P524501; V10P524501
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C22H25N3O3
|
|||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO
|
|||||
InChI |
InChI=1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+
|
|||||
InChIKey |
BWDQBBCUWLSASG-MDZDMXLPSA-N
|
|||||
Pharmaceutical Properties | Molecular Weight | 379.5 | Topological Polar Surface Area | 88.6 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
2.6
|
|||||
PubChem CID | ||||||
ChEBI ID |
ChEBI:50692
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.